Show simple item record

dc.contributor.authorErden, Zeynep
dc.contributor.authorvon Krogh, Georg
dc.date.accessioned2018-04-13T09:17:37Z
dc.date.available2018-04-13T09:17:37Z
dc.date.issued2011
dc.identifier.issn1359-6446
dc.identifier.doi10.1016/j.drudis.2011.03.001
dc.identifier.urihttp://hdl.handle.net/20.500.12127/5947
dc.description.abstractClusters are groups of co-located and interconnected firms and institutions linked by commonalities in their strategies and complementarities in their activities and resources. There are several reasons for the geographical clustering of firms in the biopharmaceutical industry. This review unpacks some advantages and disadvantages of cluster participation, and proposes a new method to enable managers and researchers to identify clusters in the biopharmaceutical industry.
dc.language.isoen
dc.publisherElsevier
dc.subjectClusters
dc.titleClusters in the biopharmaceutical industry: Toward a new method of analysis
dc.identifier.journalDrug Discovery Today
dc.source.volume16
dc.source.issue9-10
dc.source.beginpage450
dc.source.endpage456
dc.contributor.departmentETH Zurich
vlerick.knowledgedomainEntrepreneurship
vlerick.knowledgedomainSpecial Industries : Healthcare Management
vlerick.knowledgedomainStrategy
vlerick.typearticleJournal article with impact factor
dc.identifier.vperid237517


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record